Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Registration
    • Conference Registration
    • Exhibitor Registration
    • Hotel Reservations
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • App View

Fragment Based Drug Discovery of Allosteric FAK Inhibitors

Undergraduate #4
Discipline: Biological Sciences
Subcategory: Cancer Research

Osvaldo Cossio - University of Arkansas at Little Rock
Co-Author(s): Ramon Campos-Olivas, Clara Santiveri, Daniel Lietha, and Marta Acebron, Spanish National Cancer Research Centre (CNIO), Madrid Spain



The Focal Adhesion Kinase (FAK) is a cytoplasmic tyrosine kinase that plays a key role in cell matrix adhesion signals. Here, signaling is essential for cell migration and proliferation. In several advanced-stage solid cancers, FAK is overexpressed and helps to promote tumor invasion and metastasis. This discovery has led to much research on developing small molecule FAK inhibitors that target the FAK Kinase Domain ATP binding site. However, due to the similarity of ATP binding sites between different kinases this raises concern on the undesired toxicities that could result. Therefore, our research focuses on finding allosteric small molecule FAK inhibitors that target the kinase function but not the active ATP-binding site. To find novel allosteric small molecule FAK inhibitors, we employed the fragment-based drug discovery approach. A collection of about 500 fluorinated small molecules was screened against the FAK protein target with 1D 19F Nuclear Magnetic Resonance (NMR). To identify the binding between small molecules and FAK protein targets, the increase in the small molecules 19F NMR signal linewidth was used. The hits identified in our research represent potential fragments that can be used to further develop them into lead compounds possessing drug-like properties against this protein overexpressed in cancer. Our future studies will involve further characterizing the hits with WaterLOGSY (WL) and saturation transfer difference (STD) NMR experiments, SPR analysis, and crystallography.

Funder Acknowledgement(s): Spanish National Cancer Research Centre (CNIO)

Faculty Advisor: Janet Lanza,

ERN Conference

Celebrating 10 years of ERN!

What’s New

  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • #ShutDownSTEM
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

Navigation

  • About the ERN Conference
  • Partners/Supporters
  • Abstracts
  • Travel Awards
  • Conference Registration
  • Exhibitor Registration
  • Hotel Reservations

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2021 American Association for the Advancement of Science